PostAds (PTAD) 10-Q 15 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 13, 2023
Cover [Abstract]
Entity Registrant Name	GLACIER WORLDWIDE, INC.
Entity Central Index Key	0001655971
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	No
Document Period End Date	Sep. 30, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Entity Common Stock Shares Outstanding		101,244,400
Entity File Number	333-208931
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	35-2539888
Entity Address Address Line 1	10390 Santa Monica Boulevard
Entity Address City Or Town	Los Angeles
Entity Address State Or Province	CA
Entity Address Postal Zip Code	90025
City Area Code	310
Local Phone Number	359-6791
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current Assets
Cash	$ 193,778	$ 53,699
Prepaid expenses	25,000	0
Total current assets	218,778	53,699
Total Assets	218,778	53,699
Current Liabilities
Accounts payable and accrued liabilities	135,956	94,579
Due to related party	18,860	15,998
Total current liabilities	154,816	110,577
Total Liabilities	154,816	110,577
Stockholders' Equity (Deficit)
Series A Preferred stock: 10,000,000 shares authorized; $0.001 par value, no shares issued and outstanding	0	0
Common stock: 150,000,000 shares authorized; $0.001 par value, 100,902,400 shares and 100,617,900 shares issued and outstanding as of September 30,2023 and December 31,2022, respectively	100,902	100,618
Additional paid in capital	427,699	285,733
Subscription received - shares to be issued	141,000	0
Accumulated deficit	(605,639)	(443,229)
Total Stockholders' Equity (Deficit)	63,962	(56,878)
Total Liabilities and Stockholders' Equity (Deficit)	$ 218,778	$ 53,699

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Condensed Consolidated Balance Sheets
Series A preferred stock, par value	$ 0.001	$ 0.001
Series A preferred stock, shares authorized	10,000,000	10,000,000
Series A preferred stock, shares issued	0	0
Series A preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	100,902,400	100,617,900
Common stock, shares outstanding	100,902,400	100,617,900

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Condensed Consolidated Statements of Operations (Unaudited)
Revenues	$ 0	$ 0	$ 0	$ 0
Operating Expenses
General and administrative	528	429	1,743	982
Professional fees	52,311	22,016	160,668	91,721
Total Operating Expenses	52,839	22,445	162,411	92,703
Loss from operations	(52,839)	(22,445)	(162,411)	(92,703)
Other Income
Interest income	0	2	1	9
Net Other Income	0	2	1	9
Loss Before Provision for Income Taxes	(52,839)	(22,443)	(162,410)	(92,694)
Provision for Income Taxes	0	0	0	0
Net Loss	$ (52,839)	$ (22,443)	$ (162,410)	$ (92,694)
Net loss per common share: Basic and Diluted	$ 0	$ 0	$ 0	$ 0
Weighted average number of common shares outstanding: Basic and Diluted	100,852,922	100,617,900	100,696,812	100,554,659

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders Deficit (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Common stock to be Issued	Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2021		100,076,400
Balance, amount at Dec. 31, 2021	$ 61,892	$ 100,076	$ 15,525	$ 270,750	$ (324,459)
Issuance common stock related to subscription, shares		541,500
Issuance common stock related to subscription, amount	0	$ 542	270,208	(270,750)	0
Net loss	(27,153)	$ 0	0	0	(27,153)
Balance, shares at Mar. 31, 2022		100,617,900
Balance, amount at Mar. 31, 2022	34,739	$ 100,618	285,733	0	(351,612)
Balance, shares at Dec. 31, 2021		100,076,400
Balance, amount at Dec. 31, 2021	61,892	$ 100,076	15,525	270,750	(324,459)
Net loss	(92,694)
Balance, shares at Sep. 30, 2022		100,617,900
Balance, amount at Sep. 30, 2022	(30,802)	$ 100,618	285,733	0	(417,153)
Balance, shares at Mar. 31, 2022		100,617,900
Balance, amount at Mar. 31, 2022	34,739	$ 100,618	285,733	0	(351,612)
Net loss	(43,098)	$ 0	0	0	(43,098)
Balance, shares at Jun. 30, 2022		100,617,900
Balance, amount at Jun. 30, 2022	(8,359)	$ 100,618	285,733	0	(394,710)
Net loss	(22,443)	$ 0	0	0	(22,443)
Balance, shares at Sep. 30, 2022		100,617,900
Balance, amount at Sep. 30, 2022	(30,802)	$ 100,618	285,733	0	(417,153)
Balance, shares at Dec. 31, 2022		100,617,900
Balance, amount at Dec. 31, 2022	(56,878)	$ 100,618	285,733	0	(443,229)
Net loss	(67,421)	$ 0	0	0	(67,421)
Balance, shares at Mar. 31, 2023		100,617,900
Balance, amount at Mar. 31, 2023	(124,299)	$ 100,618	285,733	0	(510,650)
Balance, shares at Dec. 31, 2022		100,617,900
Balance, amount at Dec. 31, 2022	(56,878)	$ 100,618	285,733	0	(443,229)
Net loss	(162,410)
Balance, shares at Sep. 30, 2023		100,902,400
Balance, amount at Sep. 30, 2023	63,962	$ 100,902	427,699	141,000	(605,639)
Balance, shares at Mar. 31, 2023		100,617,900
Balance, amount at Mar. 31, 2023	(124,299)	$ 100,618	285,733	0	(510,650)
Net loss	(42,150)	0	0	0	(42,150)
Subscription received - shares to be issued	142,250	$ 0	0	142,250	0
Balance, shares at Jun. 30, 2023		100,617,900
Balance, amount at Jun. 30, 2023	(24,199)	$ 100,618	285,733	142,250	(552,800)
Issuance common stock related to subscription, shares		284,500
Issuance common stock related to subscription, amount	0	$ 284	141,966	(142,250)	0
Net loss	(52,839)	0	0	0	(52,839)
Subscription received - shares to be issued	141,000	$ 0	0	141,000	0
Balance, shares at Sep. 30, 2023		100,902,400
Balance, amount at Sep. 30, 2023	$ 63,962	$ 100,902	$ 427,699	$ 141,000	$ (605,639)

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (162,410)	$ (92,694)
Changes in current assets and liabilities:
Prepaid expenses	(25,000)	0
Accounts payable	41,377	6,946
Due to related party	2,862	313
Net cash used in operating activities	(143,171)	(85,435)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceed from stock subscription	283,250	0
Net cash provided by Financing Activities	283,250	0
Net cash increase for the period	140,079	(85,435)
Cash at beginning of period	53,699	173,139
Cash at end of period	193,778	87,704
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes	0	0
Cash paid for interest	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES
Issuance of common stock for stock subscription to be issued	$ 0	$ 270,750

ORGANIZATION BUSINESS AND GOING

ORGANIZATION BUSINESS AND GOING CONCERN	9 Months Ended
	Sep. 30, 2023
ORGANIZATION BUSINESS AND GOING CONCERN
ORGANIZATION, BUSINESS AND GOING CONCERN	NOTE 1 ORGANIZATION, BUSINESS AND GOING CONCERN Organization and Operation Glacier Worldwide, Inc. (the “Company”) was formed on August 17, 2015, originally as PostAds, Inc., in the State of Nevada as a reorganization of a sole proprietor business with an inception date of August 26, 2013. On January 6, 2021, the Company changed its name to Glacier Worldwide, Inc. (the “Company”). The Company has no operations and currently has no planned principal operations. Its activities since inception include devoting substantially all of its efforts to business planning and development. The Company has generated only nominal revenue from operations. The Company’s activities during this development stage are subject to significant risks and uncertainties. Going Concern The accompanying condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplates the Company’s continuation as a going concern. The Company has incurred operating losses of $162,410 for the nine months ended September 30, 2023, and has an accumulated deficit of $605,639 as of September 30, 2023. Management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, shareholder loans, and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or Due to uncertainties related to these matters, there exists a substantial doubt about the ability of the Company to continue as a going concern. The accompanying condensed consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2023
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended December 31, 2022, as filed with the SEC on March 29, 2023. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Drnq Budz Inc. All significant inter-company balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements. Cash Cash consists of cash and highly liquid investments with remaining maturities of less than ninety days at the date of purchase. We maintain cash and cash equivalent balances with financial institutions that exceed federally-insured limits. We have not experienced any losses related to these balances, and we believe the credit risk to be minimal. The Company does not have any cash equivalents.

PREPAID EXPENSES

PREPAID EXPENSES	9 Months Ended
	Sep. 30, 2023
PREPAID EXPENSES
PREPAID EXPENSES	NOTE 3 – PREPAID EXPENSES As of September 30, 2023, prepaid expenses consisted solely of professional fees paid in advance.

RELATED PARTY CONSIDERATIONS

RELATED PARTY CONSIDERATIONS	9 Months Ended
	Sep. 30, 2023
RELATED PARTY CONSIDERATIONS
RELATED PARTY CONSIDERATIONS	NOTE 4 - RELATED PARTY CONSIDERATIONS During the nine months ended September 30, 2023, and 2022, the Company’s Principal Executive Officer advanced to the Company $3,000 and $313, respectively, by paying operating expenses on behalf of the Company. During the nine months ended September 30, 2023, the Company reimbursed $138 due to a former related party for operating expenses paid on behalf of the Company. As of September 30, 2023, and December 31, 2022, the Company was obliged to the Principal Executive Officer, for an unsecured, noninterest bearing demand loan balance of $18,860 and $15,998, respectively.

STOCKHOLDERS EQUITY

STOCKHOLDERS EQUITY	9 Months Ended
	Sep. 30, 2023
STOCKHOLDERS EQUITY
STOCKHOLDERS EQUITY	NOTE 5 - STOCKHOLDERS’ EQUITY Preferred Stock The Company has authorized 10,000,000 shares of Preferred Stock with a par value of $0.001 per share. The Board of Directors is authorized to divide the authorized shares of Preferred Stock into one or more series, each of which shall be so designated as to distinguish the shares thereof from the shares of all other series and classes. As of September 30, 2023, and December 31, 2022, the Company had no shares of Preferred Stock issued and outstanding. Common Stock The Company has authorized 150,000,000 shares of Common Stock with a par value of $0.001 per share. Each share of Common Stock entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. During the nine months ended September 30, 2022, the Company issued 541,500 shares of Common Stock in respect of a subscription of $270,750 received during the year ended December 31, 2021. During the nine months ended September 30, 2023, the Company issued 284,500 shares of Common Stock in respect of a subscription of $142,250 received during the nine months ended September 30, 2023. As at September 30, 2023 and December 31, 2022, the Company had 100,902,400 shares and 100,617,900 shares of Common Stock issued and outstanding, respectively.

SUBSCRIPTIONS RECEIVED SHARES T

SUBSCRIPTIONS RECEIVED SHARES TO BE ISSUED	9 Months Ended
	Sep. 30, 2023
SUBSCRIPTIONS RECEIVED SHARES TO BE ISSUED
SUBSCRIPTIONS RECEIVED - SHARES TO BE ISSUED	NOTE 6 – SUBSCRIPTIONS RECEIVED – SHARES TO BE ISSUED During the nine months ended September 30, 2023, the Company received subscriptions of $141,000 for 282,000 shares of common stock which have yet to be issued. As of September 30, 2023, 282,000 shares of common stock were not yet issued, and the Company recorded $141,000 as common stock to be issued.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2023
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 7 - SUBSEQUENT EVENTS Subsequent to the period ended September 30, 2023, the Company issued 282,000 shares of common stock for subscription received during the nine months ended September 30, 2023.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2023
SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim condensed consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended December 31, 2022, as filed with the SEC on March 29, 2023.
Principles of Consolidation	The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Drnq Budz Inc. All significant inter-company balances and transactions have been eliminated in consolidation.
Use of Estimates	The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.
Recent Accounting Pronouncements	The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements.
Cash	Cash consists of cash and highly liquid investments with remaining maturities of less than ninety days at the date of purchase. We maintain cash and cash equivalent balances with financial institutions that exceed federally-insured limits. We have not experienced any losses related to these balances, and we believe the credit risk to be minimal. The Company does not have any cash equivalents.

ORGANIZATION BUSINESS AND GOI_2

ORGANIZATION BUSINESS AND GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
ORGANIZATION BUSINESS AND GOING CONCERN
Accumulated deficit	$ (605,639)						$ (605,639)		$ (443,229)
Net Loss	$ (52,839)	$ (42,150)	$ (67,421)	$ (22,443)	$ (43,098)	$ (27,153)	$ (162,410)	$ (92,694)

RELATED PARTY CONSIDERATIONS (D

RELATED PARTY CONSIDERATIONS (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
RELATED PARTY CONSIDERATIONS
Due to related party	$ 18,860		$ 15,998
Operating expenses due to related party	3,000	$ 313
Reimbursed operating expenses due to related party	$ 138

STOCKHOLDERS EQUITY (Details Na

STOCKHOLDERS EQUITY (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2021	Dec. 31, 2022
STOCKHOLDERS EQUITY
Preferred stock, par value	$ 0.001		$ 0.001
Preferred stock shares, authorized	10,000,000		10,000,000
Preferred Stock shares, issued	0		0
Preferred Stock shares, outstanding	0		0
Common stock, par value	$ 0.001		$ 0.001
Common stock shares, authorized	150,000,000		150,000,000
Common stock shares, issued	100,902,400		100,617,900
Common stock shares, outstanding	100,902,400		100,617,900
Issuance common stock related to subscription, shares	541,500	284,500
Issuance common stock related to subscription, amount	$ 270,750	$ 142,250

SUBSCRIPTIONS RECEIVED SHARES_2

SUBSCRIPTIONS RECEIVED SHARES TO BE ISSUED (Details Narrative)	9 Months Ended
	Sep. 30, 2023 USD ($) shares
SUBSCRIPTIONS RECEIVED SHARES TO BE ISSUED
Common stock, shares, subscriptions | shares	141,000
Common stock, value, subscriptions | $	$ 282,000
Common stock share not yet issued | shares	282,000
Common stock to be issued | $	$ 141,000